887 Angiotensin receptor blockers and/or angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation. Meta-analysis of randomized controlled clinical trials

Meta Analysis ◽

Angiotensin Receptor ◽

Controlled Clinical Trials ◽

Randomized Controlled Clinical Trials ◽

Randomized Controlled ◽

887 Angiotensin receptor blockers and/or angiotensin-converting enzyme inhibitors in the prevention of atrial fibrillation. Meta-analysis of randomized controlled clinical trials

EP Europace ◽

10.1016/s1099-5129(05)80620-8 ◽

2005 ◽

Vol 7 ◽

pp. 211-211

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Angiotensin Receptor ◽

Controlled Clinical Trials ◽

Randomized Controlled Clinical Trials ◽

Randomized Controlled ◽

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CARDIOVASCULAR RISK FACTORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(15)61423-1 ◽

2015 ◽

Vol 65 (10) ◽

pp. A1423

Author(s):

Vu Linh Hoang ◽

Daniel Addison ◽

Don Pham ◽

Mahboob Alam ◽

Yochai Birnbaum

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CORONARY ARTERY DISEASE AND NO CLINICAL EVIDENCE OF HEART FAILURE: A META-ANALYSIS OF RANDOMIZED-CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)61428-5 ◽

2014 ◽

Vol 63 (12) ◽

pp. A1428

Author(s):

Vu Linh Hoang ◽

Daniel Addison ◽

Yochai Birnbaum ◽

Francisco Macedo ◽

Mahboob Alam

Keyword(s):

Clinical Evidence ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN RECEPTOR BLOCKERS ON RISK OF MORTALITY: A META-ANALYSIS OF RANDOMIZED-CONTROLLED TRIALS INVOLVING 317,984 PATIENTS

Journal of Hypertension ◽

10.1097/01.hjh.0000746700.43368.89 ◽

2021 ◽

Vol 39 (Supplement 1) ◽

pp. e200-e201

Author(s):

Manal Alosaimi ◽

Nur Aishah Che Roos ◽

Anwar Mansour Alnakhli ◽

John G.F. Cleland ◽

Sandosh Padmanabhan

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Risk Of Mortality ◽

Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: A meta-analysis of randomized controlled trials

Clinical Nephrology ◽

10.5414/cn109193 ◽

2018 ◽

Vol 89 (6) ◽

pp. 445-454 ◽

Cited By ~ 2

Author(s):

Yue Yang ◽

Ye-ping Ma ◽

Zheng Zhang ◽

Pei-lin Dai ◽

Ping Li ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-016-6652-7 ◽

2016 ◽

Vol 30 (2) ◽

pp. 189-198 ◽

Cited By ~ 5

Author(s):

Vu Hoang ◽

Mahboob Alam ◽

Daniel Addison ◽

Francisco Macedo ◽

Salim Virani ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease

Safety of the Combination of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Heart Failure: A Systematic Review and Meta Analysis of Randomized Controlled Trials

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2006.06.248 ◽

2006 ◽

Vol 12 (6) ◽

pp. S73

Author(s):

Rachid Lakhdar ◽

Mouaz H. Al-Mallah

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Patients With Heart Failure ◽

Erratum to: Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-016-6657-2 ◽

2016 ◽

Vol 30 (2) ◽

pp. 199-199

Author(s):

Vu Hoang ◽

Mahboob Alam ◽

Daniel Addison ◽

Francisco Macedo ◽

Salim Virani ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease

Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Journal of Clinical Hypertension ◽

10.1111/jch.14329 ◽

2021 ◽

Author(s):

Na Jia ◽

Guifang Zhang ◽

Xuelin Sun ◽

Yan Wang ◽

Sai Zhao ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Systemic Review ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

All Cause Mortality ◽

ANGIOTENSIN RECEPTOR BLOCKERS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN COVID-19 –META-ANALYSIS/META-REGRESSION ADJUSTED FOR CONFOUNDING FACTORS

CJC Open ◽

10.1016/j.cjco.2021.03.001 ◽

2021 ◽

Author(s):

TERRY LEE ◽

A CAU ◽

MP CHENG ◽

A LEVIN ◽

TC LEE ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Confounding Factors ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Receptor Blockers ◽

Meta Regression